KURA
Kura Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.25
+0.76%2
Insider buys (3m)
3
Insider sells (3m)
$1.1M
Net value (3m)
+49.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 24, 2026 | WILSON TROY EDWARD · director, officer: President and CEO | Purchase | 100,000 | $12 |
| Aug 24, 2026 | Powl Brian T. · officer: Chief Commercial Officer | Sale | 4,345 | $12 |
| Aug 21, 2026 | Bair Teresa Brophy · officer: Chief Legal Officer | Sale | 31,487 | $13 |
| Aug 17, 2026 | WILSON TROY EDWARD · director, officer: President and CEO | Purchase | 100,000 | $11 |
| Jun 22, 2026 | Leoni Mollie · officer: Chief Medical Officer | Sale | 84,929 | $9.82 |
| Jun 4, 2026 | Collins Helen Louise · director | A-Award | 35,000 | $8.77 |
| Jun 4, 2026 | VASCONCELLES MICHAEL · director | A-Award | 35,000 | $8.77 |
| Jun 4, 2026 | Parks Diane L. · director | A-Award | 35,000 | $8.77 |
| Jun 4, 2026 | Malley Thomas · director | A-Award | 35,000 | $8.77 |
| Jun 4, 2026 | Szela Mary T · director | A-Award | 35,000 | $8.77 |
| Jun 4, 2026 | SCHAFER CAROL · director | A-Award | 35,000 | $8.77 |
| Jun 4, 2026 | Hasnain Faheem · director | A-Award | 35,000 | $8.77 |
| May 22, 2026 | Powl Brian T. · officer: Chief Commercial Officer | Sale | 10,000 | $11 |
| May 20, 2026 | Bair Teresa Brophy · officer: Chief Legal Officer | Sale | 2,256 | $9.38 |
| May 20, 2026 | Powl Brian T. · officer: Chief Commercial Officer | Sale | 339 | $9.21 |
| May 20, 2026 | FORD KATHLEEN · officer: Chief Operating Officer | Sale | 2,257 | $9.08 |
| Mar 25, 2026 | WILSON TROY EDWARD · director, officer: President and CEO | M-Exempt | 6,103 | $6.15 |
| Mar 20, 2026 | Malley Thomas · director | M-Exempt | 10,000 | $3.12 |
| Jan 27, 2026 | Bair Teresa Brophy · officer: Chief Legal Officer | Sale | 4,096 | $8.46 |
| Jan 27, 2026 | Powl Brian T. · officer: Chief Commercial Officer | Sale | 1,572 | $8.46 |
| Jan 27, 2026 | Powl Brian T. · officer: Chief Commercial Officer | Sale | 4,842 | $8.46 |
| Jan 27, 2026 | DOYLE THOMAS JAMES · officer: SVP, Finance & Accounting | Sale | 1,114 | $8.46 |
| Jan 27, 2026 | DOYLE THOMAS JAMES · officer: SVP, Finance & Accounting | Sale | 695 | $8.46 |
| Jan 27, 2026 | DOYLE THOMAS JAMES · officer: SVP, Finance & Accounting | Sale | 881 | $8.46 |
| Jan 27, 2026 | Burrows Francis · officer: Chief Scientific Officer | Sale | 1,311 | $8.46 |
| Jan 27, 2026 | Bair Teresa Brophy · officer: Chief Legal Officer | Sale | 2,335 | $8.46 |
| Jan 27, 2026 | Bair Teresa Brophy · officer: Chief Legal Officer | Sale | 4,777 | $8.46 |
| Jan 27, 2026 | FORD KATHLEEN · officer: Chief Operating Officer | Sale | 1,813 | $8.46 |
| Jan 27, 2026 | Leoni Mollie · officer: Chief Medical Officer | Sale | 3,655 | $8.46 |
| Jan 27, 2026 | Leoni Mollie · officer: Chief Medical Officer | Sale | 2,233 | $8.46 |
Institutional positioning
13F filings over the trailing two quarters
New 66Increased 160Reduced 151Sold out 26
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 10,509,233 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 9,637,531 | May 13, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 8,575,422 | Aug 14, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 8,575,422 | May 15, 2026 |
| BVF INC/IL | Reduced | 8,445,769 | May 15, 2026 |
| BVF INC/IL | Unchanged | 8,445,769 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 5,329,208 | Aug 7, 2026 |
| STATE STREET CORP | Reduced | 4,511,891 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 3,916,164 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3,785,685 | May 15, 2026 |
| ARMISTICE CAPITAL, LLC | Reduced | 3,736,000 | May 15, 2026 |
| ARMISTICE CAPITAL, LLC | Reduced | 3,678,000 | Aug 14, 2026 |
| PROSIGHT MANAGEMENT, LP | Increased | 3,356,700 | May 15, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 3,126,727 | Aug 14, 2026 |
| DEEP TRACK CAPITAL, LP | New Position | 2,643,542 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 24, 2026